Quantcast

Latest Parkinson's disease Stories

2014-04-28 12:27:49

NEW YORK, April 28, 2014 /PRNewswire-USNewswire/ -- Founder Michael J. Fox; CEO Todd Sherer, PhD; and Co-Founder and Executive Vice Chairman Deborah W. Brooks of The Michael J. Fox Foundation for Parkinson's Research (MJFF) are featured on the cover of the inaugural issue of Clinical Researcher, the journal of the Association of Clinical Research Professionals. http://photos.prnewswire.com/prnvar/20140425/79262 The April 2014 cover story, authored by Sherer and other MJFF staff, is...

2014-04-28 08:33:12

EU support boosts development of therapeutic vaccines against Parkinson's and Multiple System Atrophy. AFFiRiS leads consortium. VIENNA, April 28, 2014 /PRNewswire/ -- An international consortium of top European research teams has received significant EU funding for the development of therapeutic vaccines against Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Led by the Austrian biotech company AFFiRiS AG, the consortium will use a novel tandem strategy to advance...

Existing Cochlear Technology Used To Re-grow Auditory Nerves
2014-04-24 03:24:49

[ Watch The Video: Bionic Ear Delivers DNA To Regrow Auditory Nerve Cells ] University of New South Wales Researchers at UNSW Australia have for the first time used electrical pulses delivered from a cochlear implant to deliver gene therapy, thereby successfully regrowing auditory nerves. The research also heralds a possible new way of treating a range of neurological disorders, including Parkinson's disease, and psychiatric conditions such as depression through this novel way...

2014-04-23 16:30:11

EMERYVILLE, Calif., April 23, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a specialty pharmaceutical company, today announced a poster presentation at the American Academy of Neurology (AAN) 66(th) Annual Meeting, April 26 to May 3, 2014, in Philadelphia, PA. http://photos.prnewswire.com/prnvar/20130618/LA33709LOGO The poster (4009), is titled, "Safety and Efficacy Study of ADS-5102 (amantadine HCl) extended release capsules in Levodopa-Induced Dyskinesia...

2014-04-23 16:29:24

NEW YORK, April 23, 2014 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) is launching a new funding program to promote collaborative analysis of subtypes of the protein alpha-synuclein. Aggregating in the cells of all people with Parkinson's disease (PD), alpha-synuclein is a major target for drug development. To advance those efforts, scientists must analyze different species of this protein -- resulting from splicing or post-translational...

2014-04-18 12:22:35

Join us at the largest grassroots event in the U.S. to raise awareness and funds for Parkinson's research KINGSTON, N.J., April 18, 2014 /PRNewswire-USNewswire/ -- The Parkinson Alliance announced today that the 20(th) Parkinson's Unity Walk will take place on Saturday, April 26, 2014, in New York City's Central Park. The Parkinson's Unity Walk is the largest grassroots event for Parkinson's disease; uniting thousands of supporters from across the country in a common goal; to raise...

2014-04-18 09:59:31

Attack by own immune system may kill neurons in Parkinson's disease The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells. The study was published April 16, 2014, in Nature Communications. "This is a new, and likely controversial,...

2014-04-16 16:13:04

New screening technique opens the door to unlimited opportunities, both in terms of chemistry and biology research Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs. The corresponding author, Professor Ronald Quinn AM said testing the new process on a marine sponge had delivered not only confirmation that the system is effective, but also a potential lead in the...

2014-04-16 08:28:05

KANSAS CITY, Mo., April 16, 2014 /PRNewswire/ -- When Jack McDonald elected to have Deep Brain Stimulation (DBS) surgery after more than a decade of watching his tremors and other symptoms get progressively worse, he saw it as a teachable moment for his grandchildren. Their reactions to his brain surgery experience were the inspiration for Poppo's Electric Brain, an educational new children's book that makes Parkinson's disease and DBS more understandable for young people. More...

2014-04-14 12:32:55

Researchers recruiting patients with mild to moderate Alzheimer's disease to participate in six week study SUN CITY, Ariz., April 14, 2014 /PRNewswire/ -- Banner Sun Health Research Institute is proud to announce it is one of just five facilities in the United States to launch a new clinical trial for patients with mild to moderate Alzheimer's disease (AD). This study, titled "Effect of NeuroAD(TM), Combined TMS Stimulation and Cognitive Training, on the cognitive function of mild to...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related